2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Terminated
1
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Conditions
Breast Neoplasms
1236
Neoplasms
1040
Carcinoma, Non-Small-Cell Lung
861
Prostatic Neoplasms
692
Colorectal Neoplasms
614
Lung Neoplasms
578
Neoplasm Metastasis
439
Multiple Myeloma
425
Leukemia, Myeloid, Acute
401
Pancreatic Neoplasms
376
Ovarian Neoplasms
364
Melanoma
320
Carcinoma, Hepatocellular
288
Recurrence
276
Squamous Cell Carcinoma of Head and Neck
275
Brain Neoplasms
266
Glioblastoma
247
Head and Neck Neoplasms
244
Stomach Neoplasms
239
Carcinoma, Renal Cell
228
Precursor Cell Lymphoblastic Leukemia-Lymphoma
227
Lymphoma
225
Triple Negative Breast Neoplasms
219
Hematologic Neoplasms
209
Endometrial Neoplasms
209
Urinary Bladder Neoplasms
202
Lymphoma, Non-Hodgkin
197
Uterine Cervical Neoplasms
194
Sarcoma
190
Glioma
190
Interventions
tusamitamab ravtansine
1
Platinum
1
Docetaxel
1
Bevacizumab
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Non-small Cell Lung Cancer Metastatic
×
90 days
×
Clear all
NCT04154956
2026-05-18
CARMEN-LC03
Sanofi
Phase 3
Terminated
389 enrolled
16 charts
NCT05407155
2026-04-23
BETTER
Fudan University
Phase NA
Active not recruiting
56 enrolled